自然免疫系と適応免疫系の両方の研究が進み、感染症と戦い、免疫不全を緩和し、自己免疫疾患やがんと戦う能力にブレークスルーがもたらされました。疾患や治療のメカニズムを解明する一貫した結果を得るためには、信頼性の高い、検証済みの抗体が不可欠です。Cell Signaling Technology (CST) は、新しい免疫療法の開発や疾患における免疫の役割について、重要な知見を得るためにご利用いただける抗体を幅広くご提供しています。当社エキスパートの研究者たちと検証済み製品の包括的なセレクションで、お客様の最も重要な研究ニーズに対応したソリューションを提供させていただきます。
Choosing the right antibody for immunophenotyping is critical to understanding the role of the immune system in diseases such as cancer. Applications like immunohistochemistry (IHC) and flow cytometry allow for multiplex monitoring of cell populations and both require stringent validation principles. Our CST antibody catalog is your source for leading immunophenotyping products.
The ability to understand immune regulatory mechanisms of cancer enables the development of novel approaches to activate therapeutic anti-tumor immunity. At CST, we offer scientific expertise and a wide selection of validated antibodies to help you get reliable and efficient data for a range of immuno-oncology techniques.
The regulation of immune cells occurs through a number of key signaling pathways involving a complex network of proteins that interact with one another, resulting in a distinct cellular response. CST has an extensive catalog of validated antibodies that can be applied to elucidate understanding of how immune signaling pathways control the function of the immune system during response to infection, disease pathogenesis, and immunotherapy.
CST offers a diverse catalog of validated assays for the characterization of immune cell function including cytotoxicity assays, proliferation assays, and ELISAs that enable observation immune pathway activation. Our scientists can provide direction for choosing assays and protocols that enable the generation of high-quality data.